Deep Vein Thrombosis Prophylaxis Guidelines

Introduction to DVT Prophylaxis

The American College of Chest Physicians recommends that DVT prophylaxis should be tailored based on patient risk factors and procedure type, with pharmacologic prophylaxis recommended for most hospitalized patients and those undergoing major surgery, while mechanical methods should be used when pharmacologic methods are contraindicated or as adjunctive therapy 1, 2

Risk stratification is essential for determining appropriate DVT prophylaxis, considering both patient-specific factors and procedure-related risks 2, 3
Patient risk factors include age >60 years, malignancy, previous VTE, obesity, restricted mobility, smoking, and venous varicosities 3
Procedures can be categorized as low, moderate, high, or very high risk based on type and duration 2, 4

Low Molecular Weight Heparin (LMWH) is a first-line option for most hospitalized patients and those undergoing major surgery 1, 5
Standard dosing for LMWH includes enoxaparin 40 mg subcutaneously once daily 6, 2
Unfractionated Heparin (UFH) is an alternative when LMWH is unavailable or contraindicated, with dosing based on risk level 1, 7
Fondaparinux is an alternative option, particularly useful in patients with a history of heparin-induced thrombocytopenia 6

Intermittent pneumatic compression (IPC) devices and graduated compression stockings are recommended for patients when pharmacologic prophylaxis is contraindicated due to bleeding risk 2, 3
Early ambulation is recommended for low-risk patients 2, 3
Mechanical methods can be used in combination with pharmacologic methods for high-risk patients 5, 1

All hospitalized patients with active malignancy, acute medical illness, or reduced mobility should receive pharmacologic thromboprophylaxis unless contraindicated 1, 8
All patients undergoing major surgical procedures should receive prophylaxis, with prophylaxis beginning preoperatively when appropriate and continuing for at least 7-10 days postoperatively 5, 1
Extended prophylaxis (up to 4 weeks) should be considered for high-risk patients undergoing major abdominal or pelvic surgery 5, 1

For patients with creatinine clearance <30 ml/min, reduce enoxaparin to 30 mg once daily 2
When pharmacologic prophylaxis is contraindicated due to bleeding risk, use mechanical methods (IPC or graduated compression stockings) 1, 3